Lexaria Bioscience Corp.
Rank 80
About
Lexaria Bioscience has several sister companies and wholly-owned subsidiaries that support its aim to be a global leader in gastrointestinal delivery and orally administered products. They are currently pursuing commercial opportunities in nicotine, pharmaceuticals, and hemp, producing a range of products that include patches, cremes, and lotions.
$0.2946
USD
-3.39%
Market cap
$26,392,356
Total volume
$8,879
Shares outstanding
89,587,090
Reserved shares
194,966,196
Rank 80
About
Lexaria Bioscience has several sister companies and wholly-owned subsidiaries that support its aim to be a global leader in gastrointestinal delivery and orally administered products. They are currently pursuing commercial opportunities in nicotine, pharmaceuticals, and hemp, producing a range of products that include patches, cremes, and lotions.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
LXRP |
$8,879
|
100% |
$0.2946
|
Chart